TIDE analysis revealed that GBM patients with MAN1C1High expression had high infiltration of MDSCs and M2 TAMs, whereas patients with low MAN1C1 expression had much greater infiltration of CAFs (Supplementary Fig. S7E-F). This evidence concerns the gene MAN1C1 and glioblastoma.